Insider Transactions in Q4 2020 at 9 Meters Biopharma, Inc. (NMTR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
61,538
+32.24%
|
$0
$0.65 P/Share
|
|
Dec 15
2020
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
230,769
+22.97%
|
$0
$0.65 P/Share
|
|
Dec 15
2020
|
John Temperato Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
153,846
+13.6%
|
$0
$0.65 P/Share
|
|
Nov 27
2020
|
John Temperato Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
203,667
+19.82%
|
-
|
|
Oct 30
2020
|
John Temperato Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
4,513
+0.72%
|
-
|
|
Oct 30
2020
|
Mark A Sirgo Director |
BUY
Other acquisition or disposition
|
Direct |
4,513
+0.82%
|
-
|
|
Oct 30
2020
|
Nissim Darvish Director |
BUY
Other acquisition or disposition
|
Indirect |
1,943,734
+7.03%
|
-
|
|
Oct 30
2020
|
Orbi Med Israel Gp Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,943,734
+7.03%
|
-
|